| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 324.15B | 330.19B | 322.76B | 300.41B | 289.14B | 299.98B |
| Gross Profit | 223.11B | 227.97B | 222.57B | 211.20B | 205.52B | 204.15B |
| EBITDA | 23.23B | 35.79B | 29.55B | 30.10B | 38.63B | 39.70B |
| Net Income | 3.00B | 15.11B | 7.51B | 11.66B | 18.77B | 17.79B |
Balance Sheet | ||||||
| Total Assets | 368.34B | 393.45B | 383.12B | 371.66B | 359.60B | 320.02B |
| Cash, Cash Equivalents and Short-Term Investments | 91.35B | 92.46B | 113.97B | 132.85B | 116.53B | 105.28B |
| Total Debt | 10.10B | 10.65B | 11.22B | 10.21B | 9.98B | 1.42B |
| Total Liabilities | 78.22B | 88.67B | 92.49B | 88.62B | 84.25B | 65.75B |
| Stockholders Equity | 270.14B | 284.19B | 272.30B | 266.16B | 258.99B | 238.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.92B | -382.00M | 27.06B | 16.01B | 14.86B |
| Operating Cash Flow | 0.00 | 11.14B | 18.38B | 30.44B | 20.26B | 17.80B |
| Investing Cash Flow | 0.00 | -17.74B | -8.93B | -11.23B | -6.31B | -4.72B |
| Financing Cash Flow | 0.00 | -10.00B | -8.68B | -9.68B | -7.31B | -14.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥412.66B | 16.83 | 9.09% | 1.73% | 2.22% | 30.25% | |
71 Outperform | ¥547.32B | 13.97 | 12.66% | 1.53% | 13.61% | 17.62% | |
70 Outperform | ¥2.65T | 20.42 | 11.50% | 2.41% | 3.70% | 12.22% | |
69 Neutral | ¥318.40B | 13.05 | 2.72% | 2.61% | 2.30% | 101.20% | |
69 Neutral | ¥284.94B | 39.57 | 5.84% | 3.92% | -0.04% | 2.00% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥1.26T | 68.83 | ― | 2.11% | -2.08% | -276.11% |